medivant tirzepatide FDA Grants a New Indication for Obesity Management Brightmeds: Important Mounjaro® (tirzepatide) Safety
Description
We provide continued follow-up, progress monitoring, and program adjustments when appropriate
Most people continue to lose weight for several months before reaching a steady phase
& Wang, C
Gallbladder problems, including gallstones and biliary colic, have been reported in semaglutide users, particularly those with rapid weight loss
